671 related articles for article (PubMed ID: 28170391)
1. Haemolysis in G6PD Heterozygous Females Treated with Primaquine for Plasmodium vivax Malaria: A Nested Cohort in a Trial of Radical Curative Regimens.
Chu CS; Bancone G; Moore KA; Win HH; Thitipanawan N; Po C; Chowwiwat N; Raksapraidee R; Wilairisak P; Phyo AP; Keereecharoen L; Proux S; Charunwatthana P; Nosten F; White NJ
PLoS Med; 2017 Feb; 14(2):e1002224. PubMed ID: 28170391
[TBL] [Abstract][Full Text] [Related]
2. Chloroquine Versus Dihydroartemisinin-Piperaquine With Standard High-dose Primaquine Given Either for 7 Days or 14 Days in Plasmodium vivax Malaria.
Chu CS; Phyo AP; Turner C; Win HH; Poe NP; Yotyingaphiram W; Thinraow S; Wilairisak P; Raksapraidee R; Carrara VI; Paw MK; Wiladphaingern J; Proux S; Bancone G; Sriprawat K; Lee SJ; Jeeyapant A; Watson J; Tarning J; Imwong M; Nosten F; White NJ
Clin Infect Dis; 2019 Apr; 68(8):1311-1319. PubMed ID: 30952158
[TBL] [Abstract][Full Text] [Related]
3. Single Low Dose Primaquine (0.25 mg/kg) Does Not Cause Clinically Significant Haemolysis in G6PD Deficient Subjects.
Bancone G; Chowwiwat N; Somsakchaicharoen R; Poodpanya L; Moo PK; Gornsawun G; Kajeechiwa L; Thwin MM; Rakthinthong S; Nosten S; Thinraow S; Nyo SN; Ling CL; Wiladphaingern J; Kiricharoen NL; Moore KA; White NJ; Nosten F
PLoS One; 2016; 11(3):e0151898. PubMed ID: 27010542
[TBL] [Abstract][Full Text] [Related]
4. Primaquine alternative dosing schedules for preventing malaria relapse in people with Plasmodium vivax.
Milligan R; Daher A; Villanueva G; Bergman H; Graves PM
Cochrane Database Syst Rev; 2020 Aug; 8():CD012656. PubMed ID: 32816320
[TBL] [Abstract][Full Text] [Related]
5. Implications of current therapeutic restrictions for primaquine and tafenoquine in the radical cure of vivax malaria.
Watson J; Taylor WRJ; Bancone G; Chu CS; Jittamala P; White NJ
PLoS Negl Trop Dis; 2018 Apr; 12(4):e0006440. PubMed ID: 29677199
[TBL] [Abstract][Full Text] [Related]
6. Primaquine at alternative dosing schedules for preventing relapse in people with Plasmodium vivax malaria.
Milligan R; Daher A; Graves PM
Cochrane Database Syst Rev; 2019 Jul; 7(7):CD012656. PubMed ID: 31274189
[TBL] [Abstract][Full Text] [Related]
7. Optimal balance of benefit versus risk for tafenoquine in the treatment of Plasmodium vivax malaria.
Sharma R; Sharma H; Jones S; Borghini-Fuhrer I; Domingo GJ; Gibson RA; Rolfe K; Tan L; Fiţa IG; Chen C; Bird P; Pingle A; Duparc S
Malar J; 2024 May; 23(1):145. PubMed ID: 38741094
[TBL] [Abstract][Full Text] [Related]
8. Primaquine-induced haemolysis in females heterozygous for G6PD deficiency.
Chu CS; Bancone G; Nosten F; White NJ; Luzzatto L
Malar J; 2018 Mar; 17(1):101. PubMed ID: 29499733
[TBL] [Abstract][Full Text] [Related]
9. Dynamics of G6PD activity in patients receiving weekly primaquine for therapy of Plasmodium vivax malaria.
Taylor WRJ; Kim S; Kheng S; Muth S; Tor P; Christophel E; Mukaka M; Kerleguer A; Luzzatto L; Baird JK; Menard D
PLoS Negl Trop Dis; 2021 Sep; 15(9):e0009690. PubMed ID: 34495956
[TBL] [Abstract][Full Text] [Related]
10. Operational effectiveness of tafenoquine and primaquine for the prevention of Plasmodium vivax recurrence in Brazil: a retrospective observational study.
Brito M; Rufatto R; Brito-Sousa JD; Murta F; Sampaio V; Balieiro P; Baía-Silva D; Castro V; Alves B; Alencar A; Duparc S; Grewal Daumerie P; Borghini-Fuhrer I; Jambert E; Peterka C; Edilson Lima F; Carvalho Maia L; Lucena Cruz C; Maciele B; Vasconcelos M; Machado M; Augusto Figueira E; Alcirley Balieiro A; Batista Pereira D; Lacerda M
Lancet Infect Dis; 2024 Jun; 24(6):629-638. PubMed ID: 38452779
[TBL] [Abstract][Full Text] [Related]
11. Primaquine dose and the risk of haemolysis in patients with uncomplicated Plasmodium vivax malaria: a systematic review and individual patient data meta-analysis.
Rajasekhar M; Simpson JA; Ley B; Edler P; Chu CS; Abreha T; Awab GR; Baird JK; Bancone G; Barber BE; Grigg MJ; Hwang J; Karunajeewa H; Lacerda MVG; Ladeia-Andrade S; Llanos-Cuentas A; Pukrittayakamee S; Rijal KR; Saravu K; Sutanto I; Taylor WRJ; Thriemer K; Watson JA; Guerin PJ; White NJ; Price RN; Commons RJ;
Lancet Infect Dis; 2024 Feb; 24(2):184-195. PubMed ID: 37748497
[TBL] [Abstract][Full Text] [Related]
12. Tafenoquine for preventing relapse in people with Plasmodium vivax malaria.
Rajapakse S; Rodrigo C; Fernando SD
Cochrane Database Syst Rev; 2015 Apr; 2015(4):CD010458. PubMed ID: 25921416
[TBL] [Abstract][Full Text] [Related]
13. Tafenoquine versus Primaquine to Prevent Relapse of Plasmodium vivax Malaria.
Llanos-Cuentas A; Lacerda MVG; Hien TT; Vélez ID; Namaik-Larp C; Chu CS; Villegas MF; Val F; Monteiro WM; Brito MAM; Costa MRF; Chuquiyauri R; Casapía M; Nguyen CH; Aruachan S; Papwijitsil R; Nosten FH; Bancone G; Angus B; Duparc S; Craig G; Rousell VM; Jones SW; Hardaker E; Clover DD; Kendall L; Mohamed K; Koh GCKW; Wilches VM; Breton JJ; Green JA
N Engl J Med; 2019 Jan; 380(3):229-241. PubMed ID: 30650326
[TBL] [Abstract][Full Text] [Related]
14. Hemolytic Potential of Tafenoquine in Female Volunteers Heterozygous for Glucose-6-Phosphate Dehydrogenase (G6PD) Deficiency (
Rueangweerayut R; Bancone G; Harrell EJ; Beelen AP; Kongpatanakul S; Möhrle JJ; Rousell V; Mohamed K; Qureshi A; Narayan S; Yubon N; Miller A; Nosten FH; Luzzatto L; Duparc S; Kleim JP; Green JA
Am J Trop Med Hyg; 2017 Sep; 97(3):702-711. PubMed ID: 28749773
[TBL] [Abstract][Full Text] [Related]
15. G6PD deficiency, primaquine treatment, and risk of haemolysis in malaria-infected patients.
Avalos S; Mejia RE; Banegas E; Salinas C; Gutierrez L; Fajardo M; Galo S; Pinto A; Mejia A; Fontecha G
Malar J; 2018 Nov; 17(1):415. PubMed ID: 30409136
[TBL] [Abstract][Full Text] [Related]
16. Prevalence and distribution of G6PD deficiency: implication for the use of primaquine in malaria treatment in Ethiopia.
Lo E; Zhong D; Raya B; Pestana K; Koepfli C; Lee MC; Yewhalaw D; Yan G
Malar J; 2019 Oct; 18(1):340. PubMed ID: 31590661
[TBL] [Abstract][Full Text] [Related]
17. Tolerability and safety of weekly primaquine against relapse of Plasmodium vivax in Cambodians with glucose-6-phosphate dehydrogenase deficiency.
Kheng S; Muth S; Taylor WR; Tops N; Kosal K; Sothea K; Souy P; Kim S; Char CM; Vanna C; Ly P; Ringwald P; Khieu V; Kerleguer A; Tor P; Baird JK; Bjorge S; Menard D; Christophel E
BMC Med; 2015 Aug; 13():203. PubMed ID: 26303162
[TBL] [Abstract][Full Text] [Related]
18. Hemolytic Dynamics of Weekly Primaquine Antirelapse Therapy Among Cambodians With Acute Plasmodium vivax Malaria With or Without Glucose-6-Phosphate Dehydrogenase Deficiency.
Taylor WRJ; Kheng S; Muth S; Tor P; Kim S; Bjorge S; Topps N; Kosal K; Sothea K; Souy P; Char CM; Vanna C; Ly P; Khieu V; Christophel E; Kerleguer A; Pantaleo A; Mukaka M; Menard D; Baird JK
J Infect Dis; 2019 Oct; 220(11):1750-1760. PubMed ID: 31549159
[TBL] [Abstract][Full Text] [Related]
19. The haematological consequences of Plasmodium vivax malaria after chloroquine treatment with and without primaquine: a WorldWide Antimalarial Resistance Network systematic review and individual patient data meta-analysis.
Commons RJ; Simpson JA; Thriemer K; Chu CS; Douglas NM; Abreha T; Alemu SG; Añez A; Anstey NM; Aseffa A; Assefa A; Awab GR; Baird JK; Barber BE; Borghini-Fuhrer I; D'Alessandro U; Dahal P; Daher A; de Vries PJ; Erhart A; Gomes MSM; Grigg MJ; Hwang J; Kager PA; Ketema T; Khan WA; Lacerda MVG; Leslie T; Ley B; Lidia K; Monteiro WM; Pereira DB; Phan GT; Phyo AP; Rowland M; Saravu K; Sibley CH; Siqueira AM; Stepniewska K; Taylor WRJ; Thwaites G; Tran BQ; Hien TT; Vieira JLF; Wangchuk S; Watson J; William T; Woodrow CJ; Nosten F; Guerin PJ; White NJ; Price RN
BMC Med; 2019 Aug; 17(1):151. PubMed ID: 31366382
[TBL] [Abstract][Full Text] [Related]
20. Using G6PD tests to enable the safe treatment of Plasmodium vivax infections with primaquine on the Thailand-Myanmar border: A cost-effectiveness analysis.
Devine A; Parmiter M; Chu CS; Bancone G; Nosten F; Price RN; Lubell Y; Yeung S
PLoS Negl Trop Dis; 2017 May; 11(5):e0005602. PubMed ID: 28542194
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
